TABLE 1.
Treatment | Tube Length vs. Control (%) | Sample size (n) |
Vehicle | 100 ± 11 | 12 |
VEGF | 220 ± 34* | 5 |
8,9-EET | 209 ± 31 | 4 |
8,9,11-EHET | 242 ± 23* | 3 |
8,9,15-EHET | 85 ± 28 | 3 |
t-TUCB | 194 ± 27 | 4 |
PDBu | 681 ± 30* | 4 |
HAECs in basal media (in the absence of serum and VEGF) were seeded onto a 15-well µ-angiogenesis plates with growth factor-reduced Matrigel. Cells were then treated with vehicle (ethanol) or separately incubated with 8,9-EET (0.1 µM), 8,9,11-EHET (0.1 µM), or PDBu (1 µM). Tube length was measured manually using Fiji. The analysis was blinded toward treatments to avoid bias. Values are means ± SEs (n = 3–12). *P < 0.05 versus the control. Statistical tests were performed using one-way ANOVA with Holm-Sidak comparison to the control analysis.